KOPN - Kopin Corporation Stock Analysis | Stock Taper
Logo
Kopin Corporation

KOPN

Kopin Corporation NASDAQ
$5.71 -5.62% (-0.34)

Market Cap $1.04 B
52w High $6.45
52w Low $1.23
P/E 571.00
Volume 7.66M
Outstanding Shares 182.92M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $10.55M $10.93M $-3.75M -35.56% $-0.02 $-5.74M
Q4-2025 $8.37M $3.55M $6.81M 81.34% $0.04 $-6.45M
Q4-2025 $8.37M $8.65M $6.75M 80.65% $0.04 $-4.83M
Q3-2025 $11.96M $4.13M $4.08M 34.11% $0.02 $-372.44K
Q2-2025 $8.45M $6.84M $-5.17M -61.11% $-0.03 $-5.24M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $59.49M $102.44M $34.02M $68.42M
Q4-2025 $61.63B $108.39M $36.72M $71.67M
Q3-2025 $26.51M $61.22M $39.89M $21.32M
Q2-2025 $26.79M $61.18M $45.14M $16.04M
Q1-2025 $31.54M $65.04M $44.36M $20.68M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $-3.75M $-810.75K $-1.3M $-29.17K $-2.14M $-2.11M
Q4-2025 $6.81M $-7.86M $-2.18M $44.11M $34.07M $-7.95M
Q3-2025 $4.08M $-110.43K $2.32M $-65.05K $2.14M $-217.05K
Q2-2025 $-5.17M $-4.16M $13.28M $-89.66K $9.04M $-4.89M
Q1-2025 $-3.11M $-3.41M $4.59M $0 $1.17M $-3.91M

Revenue by Products

Product Q2-2025Q3-2025Q4-2025Q1-2026
Collaboration
Collaboration
$0 $0 $0 $0
Defense
Defense
$10.00M $10.00M $0 $10.00M
Grant
Grant
$0 $0 $0 $0
Industrial
Industrial
$0 $0 $0 $0
License and Royalties
License and Royalties
$0 $0 $0 $0
Research and Development
Research and Development
$0 $0 $0 $0
Medical
Medical
$0 $0 $0 $0

Revenue by Geography

Region Q2-2025Q3-2025Q4-2025Q1-2026
Americas
Americas
$10.00M $10.00M $10.00M $10.00M
Asia Pacific
Asia Pacific
$0 $0 $0 $0
Europe
Europe
$0 $0 $0 $0
Other Americas
Other Americas
$0 $0 $0 $0
UNITED STATES
UNITED STATES
$10.00M $10.00M $10.00M $10.00M

Q1 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Kopin Corporation's financial evolution and strategic trajectory over the past five years.

+ Strengths

Kopin combines a credible commercial footprint with strong technical depth in a specialized, high‑value segment of the display industry. It benefits from healthy gross margins, a broad and defensible IP portfolio, and entrenched relationships in U.S. defense and other mission‑critical applications. The balance sheet is robust, with substantial cash, minimal debt, and solid liquidity, giving the company room to invest and navigate volatility. Its innovation pipeline, especially in MicroLED and AI‑enhanced display architectures, provides multiple potential avenues for future growth and differentiation.

! Risks

The main risks are financial and execution‑related. Core operations are currently unprofitable and cash‑negative, with heavy overhead and R&D costs outweighing gross profit, and the recent positive net income depends on non‑operating items rather than sustainable operating performance. Historically, the company has accumulated large losses, as reflected in sharply negative retained earnings. Continued reliance on external capital or prior cash reserves is needed if operating cash flow does not improve. Strategically, Kopin also faces concentration risk in key defense and industrial programs, exposure to defense budget and policy changes, and intense technological competition from much larger players in AR/VR and display technologies.

Outlook

The outlook is balanced between opportunity and uncertainty. Kopin has the technological assets, customer relationships, and financial cushion to benefit from growing demand for advanced near‑eye displays in defense, enterprise, and medical markets, and its emerging technologies could materially enhance its competitive position if successfully commercialized. At the same time, the current business model is not yet self‑funding, and the long‑term outcome depends on the company’s ability to translate its innovation pipeline into scalable, profitable, and cash‑generative products while managing costs and concentration risks. Observers will likely focus on whether operating margins, cash flow, and program diversification improve over the next few years as key indicators of how that balance is evolving.